{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:23:02Z","timestamp":1793838182836,"version":"4.6.1"},"reference-count":178,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","award":["RES0067002"],"award-info":[{"award-number":["RES0067002"]}],"id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Psychosis, defined as a set of symptoms that results in a distorted sense of reality, is observed in several psychiatric disorders in addition to schizophrenia. This paper reviews the literature relevant to the underlying neurobiology of psychosis. The dopamine hypothesis has been a major influence in the study of the neurochemistry of psychosis and in development of antipsychotic drugs. However, it became clear early on that other factors must be involved in the dysfunction involved in psychosis. In the current review, it is reported how several of these factors, namely dysregulation of neurotransmitters [dopamine, serotonin, glutamate, and \u03b3-aminobutyric acid (GABA)], neuroinflammation, glia (microglia, astrocytes, and oligodendrocytes), the hypothalamic\u2013pituitary\u2013adrenal axis, the gut microbiome, oxidative stress, and mitochondrial dysfunction contribute to psychosis and interact with one another. Research on psychosis has increased knowledge of the complexity of psychotic disorders. Potential new pharmacotherapies, including combinations of drugs (with pre- and probiotics in some cases) affecting several of the factors mentioned above, have been suggested. Similarly, several putative biomarkers, particularly those related to the immune system, have been proposed. Future research on both pharmacotherapy and biomarkers will require better-designed studies conducted on an all stages of psychotic disorders and must consider confounders such as sex differences and comorbidity.<\/jats:p>","DOI":"10.3390\/antiox13060709","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T04:15:27Z","timestamp":1718165727000},"page":"709","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["The Underlying Neurobiological Mechanisms of Psychosis: Focus on Neurotransmission Dysregulation, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction"],"prefix":"10.3390","volume":"13","author":[{"given":"Neha S.","family":"Rawani","sequence":"first","affiliation":[{"name":"Neurochemical Research Unit and Bebensee Schizophrenia Research Unit, Department of Psychiatry and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB T6G 2G3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen W.","family":"Chan","sequence":"additional","affiliation":[{"name":"Neurochemical Research Unit and Bebensee Schizophrenia Research Unit, Department of Psychiatry and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB T6G 2G3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9943-851X","authenticated-orcid":false,"given":"Serdar M.","family":"Dursun","sequence":"additional","affiliation":[{"name":"Neurochemical Research Unit and Bebensee Schizophrenia Research Unit, Department of Psychiatry and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB T6G 2G3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-6486","authenticated-orcid":false,"given":"Glen B.","family":"Baker","sequence":"additional","affiliation":[{"name":"Neurochemical Research Unit and Bebensee Schizophrenia Research Unit, Department of Psychiatry and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB T6G 2G3, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.31887\/DCNS.2015.17.1\/wgaebel","article-title":"Focus on Psychosis","volume":"17","author":"Gaebel","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_2","unstructured":"Calabrese, J., and Al Khalili, Y. (2024). Psychosis. StatsPearls [Internet], StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1092852918001013","article-title":"Beyond the Dopamine Hypothesis of Schizophrenia to Three Neural Networks of Psychosis: Dopamine, Serotonin, and Glutamate","volume":"23","author":"Stahl","year":"2018","journal-title":"CNS Spectr."},{"key":"ref_5","first-page":"492","article-title":"The Significance of Dopamine-Receptor Blockade for the Mechanism of Action of Neuroleptic Drugs","volume":"160","year":"1966","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/syn.890010203","article-title":"Dopamine Receptors and the Dopamine Hypothesis of Schizophrenia","volume":"1","author":"Seeman","year":"1987","journal-title":"Synapse"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/0929867043456034","article-title":"Schizophrenia: From Dopamine to Glutamate and Back","volume":"11","author":"Carlsson","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41398-022-02233-0","article-title":"The Interplay of Dopamine Metabolism Abnormalities and Mitochondrial Defects in the Pathogenesis of Schizophrenia","volume":"12","author":"Xu","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41398-017-0071-9","article-title":"Dopamine, Psychosis and Schizophrenia: The Widening Gap between Basic and Clinical Neuroscience","volume":"8","author":"Kesby","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fpsyt.2018.00410","article-title":"Parallels and Overlap: The Integration of Homeostatic Signals by Mesolimbic Dopamine Neurons","volume":"9","author":"Hsu","year":"2018","journal-title":"Front. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in Schizophrenia: A Review and Reconceptualization","volume":"148","author":"Davis","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The Dopamine Hypothesis of Schizophrenia: Version III--the Final Common Pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1038\/s41380-022-01649-w","article-title":"Relevance of Interactions between Dopamine and Glutamate Neurotransmission in Schizophrenia","volume":"27","author":"Buck","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/YCO.0000000000000598","article-title":"Dopamine D2 Up-Regulation in Psychosis Patients after Antipsychotic Drug Treatment","volume":"33","author":"Thompson","year":"2020","journal-title":"Curr. Opin. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuropharm.2017.06.018","article-title":"Cannabis-Associated Psychosis: Neural Substrate and Clinical Impact","volume":"124","author":"Murray","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort","volume":"155","author":"Gil","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11920-019-1044-x","article-title":"Cannabis and Psychosis: Are We Any Closer to Understanding the Relationship?","volume":"21","author":"Hamilton","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Aryutova, K., and Stoyanov, D. (2021). Pharmaco-Magnetic Resonance as a Tool for Monitoring the Medication-Related Effects in the Brain May Provide Potential Biomarkers for Psychotic Disorders. Int. J. Mol. Sci., 22.","DOI":"10.20944\/preprints202107.0289.v1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bpsgos.2023.11.004","article-title":"The Translational Utility of Circuit-Based Manipulations in Preclinical Models","volume":"4","author":"Kesby","year":"2024","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bpsgos.2023.08.002","article-title":"Postnatal Phencyclidine-Induced Deficits in Decision Making Are Ameliorated by Optogenetic Inhibition of Ventromedial Orbitofrontal Cortical Glutamate Neurons","volume":"4","author":"Tranter","year":"2024","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and Its Implication for Treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fpsyt.2018.00544","article-title":"Astrocytic Regulation of Glutamate Transmission in Schizophrenia","volume":"9","author":"Mei","year":"2018","journal-title":"Front. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12272-017-0897-y","article-title":"Current Understanding of Methamphetamine-Associated Dopaminergic Neurodegeneration and Psychotoxic Behaviors","volume":"40","author":"Shin","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s00213-017-4695-5","article-title":"Alterations in Glutamatergic Signaling in the Brain of Dopamine Supersensitivity Psychosis and Non-Supersensitivity Psychosis Model Rats","volume":"234","author":"Oda","year":"2017","journal-title":"Psychopharmacology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e204693","DOI":"10.1001\/jamanetworkopen.2020.4693","article-title":"Association of Ketamine with Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia","volume":"3","author":"Beck","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/schbul\/sby190","article-title":"Top-Down Suppression of Sensory Cortex in an NMDAR Hypofunction Model of Psychosis","volume":"45","author":"Ranson","year":"2019","journal-title":"Schizophr. Bull."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S1461145708009814","article-title":"Haloperidol Counteracts the Ketamine-Induced Disruption of Processing Negativity, but Not That of the P300 Amplitude","volume":"12","author":"Oranje","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0006-3223(96)00546-X","article-title":"Clozapine Blunts N-Methyl-d-Aspartate Antagonist-Induced Psychosis: A Study with Ketamine","volume":"42","author":"Malhotra","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881114563634","article-title":"Glutamate and Dopamine in Schizophrenia: An Update for the 21st Century","volume":"29","author":"Howes","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.neuropharm.2011.01.030","article-title":"Contributions of the D-Serine Pathway to Schizophrenia","volume":"62","author":"Labrie","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Riederer, P., Laux, G., Nagatsu, T., Le, W., and Riederer, C. (2022). D-Serine: Basic Aspects with a Focus on Psychosis. NeuroPsychopharmacotherapy, Springer International Publishing.","DOI":"10.1007\/978-3-030-62059-2"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Riederer, P., Laux, G., Nagatsu, T., Le, W., and Riederer, C. (2022). D-Serine in the Treatment of Psychosis. NeuroPsychopharmacotherapy, Springer International Publishing.","DOI":"10.1007\/978-3-030-62059-2"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Fi\u0161ar, Z. (2023). Biological Hypotheses, Risk Factors, and Biomarkers of Schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 120.","DOI":"10.1016\/j.pnpbp.2022.110626"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mehy.2013.03.013","article-title":"A Serotonin Hypothesis of Schizophrenia","volume":"80","author":"Eggers","year":"2013","journal-title":"Med. Hypotheses"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e2710","DOI":"10.1002\/hup.2710","article-title":"Methamphetamine-Associated Psychosis: Clinical Presentation, Biological Basis, and Treatment Options","volume":"34","author":"Chiang","year":"2019","journal-title":"Hum. Psychopharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nature06612","article-title":"Identification of a Serotonin\/Glutamate Receptor Complex Implicated in Psychosis","volume":"452","author":"Ang","year":"2008","journal-title":"Nature"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41398-021-01607-0","article-title":"Neuroinflammation in Schizophrenia: The Role of Nuclear Factor Kappa B","volume":"11","author":"Murphy","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8881770","DOI":"10.1155\/2021\/8881770","article-title":"Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives","volume":"2021","author":"Ermakov","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/00325481.2021.2006514","article-title":"Neuroinflammation and Oxidative Stress in Schizophrenia: Are These Opportunities for Repurposing?","volume":"134","author":"Ansari","year":"2022","journal-title":"Postgrad. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2020.00274","article-title":"The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation","volume":"14","author":"Comer","year":"2020","journal-title":"Front. Cell Neurosci."},{"key":"ref_41","unstructured":"Khandaker, G.M., Meyer, U., and Jones, P.B. (2020). Cytokines, Oxidative Stress, and Cellular Markers of Inflammation in Schizophrenia. Neuroinflammation and Schizophrenia, Springer Nature."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbi.2023.03.014","article-title":"Serum Immune Markers and Transition to Psychosis in Individuals at Clinical High Risk","volume":"110","author":"Mondelli","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41537-023-00398-1","article-title":"Inflammatory Markers of Symptomatic Remission at 6\u2009Months in Patients with First-Episode Schizophrenia","volume":"9","author":"Kim","year":"2023","journal-title":"Schizophrenia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fnmol.2018.00186","article-title":"The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment","volume":"11","author":"Yang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/npp.2016.211","article-title":"Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.24869\/psyd.2023.8","article-title":"Monoclonal Antibody Therapy in Autoantibody-Associated Psychotic Disorders and Schizophrenia: Narrative Reviews of Past and Current Clinical Trials","volume":"35","author":"Hansen","year":"2023","journal-title":"Psychiatr. Danub."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbi.2023.10.012","article-title":"Adjunctive Canakinumab Reduces Peripheral Inflammation Markers and Improves Positive Symptoms in People with Schizophrenia and Inflammation: A Randomized Control Trial","volume":"115","author":"Weickert","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"536257","DOI":"10.3389\/fpsyt.2021.536257","article-title":"Cytokine Imbalance in Schizophrenia. From Research to Clinic: Potential Implications for Treatment","volume":"12","author":"Reale","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1007\/s12035-022-02976-3","article-title":"Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-Synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: A Systematic Review","volume":"59","author":"Barone","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2010.05.014","article-title":"Structural Brain Alterations in Schizophrenia Following Fetal Exposure to the Inflammatory Cytokine Interleukin-8","volume":"121","author":"Ellman","year":"2010","journal-title":"Schizophr. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.1998.tb09556.x","article-title":"Administration of Interleukin-1 at Birth Affects Dopaminergic Neurons in Adult Mice a","volume":"840","author":"Kabiersch","year":"1998","journal-title":"Ann. N. Y Acad. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/npp.2013.115","article-title":"Chronic Interferon-\u03b1 Decreases Dopamine 2 Receptor Binding and Striatal Dopamine Release in Association with Anhedonia-Like Behavior in Nonhuman Primates","volume":"38","author":"Felger","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"663102","DOI":"10.3389\/fimmu.2021.663102","article-title":"Immunomodulatory Effects of Dopamine in Inflammatory Diseases","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","article-title":"The Blood\u2013Brain Barrier in Psychosis","volume":"5","author":"Pollak","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fimmu.2016.00544","article-title":"Neuron-Microglia Interactions in Mental Health Disorders: \u201cFor Better, and For Worse\u201d","volume":"7","author":"Wohleb","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","article-title":"Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study","volume":"173","author":"Bloomfield","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Barron, H., Hafizi, S., Andreazza, A.C., and Mizrahi, R. (2017). Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030651"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41398-021-01385-9","article-title":"Glutamate and Microglia Activation as a Driver of Dendritic Apoptosis: A Core Pathophysiological Mechanism to Understand Schizophrenia","volume":"11","author":"Parellada","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"ref_59","first-page":"1313","article-title":"Brain in Flames\u2014Animal Models of Psychosis: Utility and Limitations","volume":"11","author":"Mattei","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Czapski, G.A., and Strosznajder, J.B. (2021). Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111677"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"239821282110091148","DOI":"10.1177\/23982128211009148","article-title":"Astrocytes in Schizophrenia","volume":"5","author":"Notter","year":"2021","journal-title":"Brain Neurosci. Adv."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2019.00040","article-title":"Mitochondrial Dysfunction in Astrocytes Impairs the Generation of Reactive Astrocytes and Enhances Neuronal Cell Death in the Cortex upon Photothrombotic Lesion","volume":"12","author":"Fiebig","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e12781","DOI":"10.1111\/cpr.12781","article-title":"The Role of Astrocytes in Oxidative Stress of Central Nervous System: A Mixed Blessing","volume":"53","author":"Chen","year":"2020","journal-title":"Cell Prolif."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Schiera, G., Di Liegro, C.M., Schir\u00f2, G., Sorbello, G., and Di Liegro, I. (2024). Involvement of Astrocytes in the Formation, Maintenance, and Function of the Blood\u2013Brain Barrier. Cells, 13.","DOI":"10.3390\/cells13020150"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1205544","DOI":"10.3389\/fnetp.2023.1205544","article-title":"Astrocytic Modulation of Neuronal Signalling","volume":"3","author":"Purushotham","year":"2023","journal-title":"Front. Network Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-45096-4_1","article-title":"Introduction to the Glutamate\u2013Glutamine Cycle","volume":"13","author":"Sonnewald","year":"2016","journal-title":"Adv. Neurobiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","article-title":"Glial Cells in Schizophrenia: A Unified Hypothesis","volume":"7","author":"Dietz","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Hashimoto, K., Engberg, G., Shimizu, E., Nordin, C., Lindstr\u00f6m, L.H., and Iyo, M. (2005). Elevated Glutamine\/Glutamate Ratio in Cerebrospinal Fluid of First Episode and Drug Naive Schizophrenic Patients. BMC Psychiatry, 5.","DOI":"10.1186\/1471-244X-5-6"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.59249\/OAMT2710","article-title":"The Importance of Cerebrospinal Fluid Investigation in First-Episode Psychosis","volume":"96","author":"Stan","year":"2023","journal-title":"Yale J. Biol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/npp.2017.242","article-title":"Reduced Density of DISC1 Expressing Astrocytes in the Dentate Gyrus but Not in the Subventricular Zone in Schizophrenia","volume":"43","author":"Bernstein","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1358450","DOI":"10.3389\/fncel.2024.1358450","article-title":"The Role of Glial Cells in Mental Illness: A Systematic Review on Astroglia and Microglia as Potential Players in Schizophrenia and Its Cognitive and Emotional Aspects","volume":"18","author":"Laricchiuta","year":"2024","journal-title":"Front. Cell Neurosci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuroscience.2016.07.012","article-title":"Curcumin Alleviates Oxidative Stress and Mitochondrial Dysfunction in Astrocytes","volume":"333","author":"Daverey","year":"2016","journal-title":"Neuroscience"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fpsyt.2017.00083","article-title":"Neurovascular Unit Dysfunction and Blood\u2013Brain Barrier Hyperpermeability Contribute to Schizophrenia Neurobiology: A Theoretical Integration of Clinical and Experimental Evidence","volume":"8","author":"Najjar","year":"2017","journal-title":"Front. Psychiatry"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune Psychosis: An International Consensus on an Approach to the Diagnosis and Management of Psychosis of Suspected Autoimmune Origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Stanca, S., Rossetti, M., Bokulic Panichi, L., and Bongioanni, P. (2024). The Cellular Dysfunction of the Brain\u2013Blood Barrier from Endothelial Cells to Astrocytes: The Pathway towards Neurotransmitter Impairment in Schizophrenia. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021250"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.psyneuen.2009.07.012","article-title":"S100B Serum Levels Are Closely Correlated with Body Mass Index: An Important Caveat in Neuropsychiatric Research","volume":"35","author":"Steiner","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Aleksovska, K., Leoncini, E., Bonassi, S., Cesario, A., Boccia, S., and Frustaci, A. (2014). Systematic Review and Meta-Analysis of Circulating S100B Blood Levels in Schizophrenia. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106342"},{"key":"ref_79","first-page":"46","article-title":"Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia\u2014A Meta-Regression Analysis","volume":"10","author":"Polyakova","year":"2016","journal-title":"Front. Cell Neurosci."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Michinaga, S., and Koyama, Y. (2019). Dual Roles of Astrocyte-Derived Factors in Regulation of Blood-Brain Barrier Function after Brain Damage. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20030571"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.22365\/jpsych.2019.303.245","article-title":"Is Psychosis a Dysmyelination-Related Information-Processing Disorder?","volume":"30","author":"Giotakos","year":"2019","journal-title":"Psychiatriki"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1038\/s41598-019-41679-z","article-title":"Cognitive Correlates of Abnormal Myelination in Psychosis","volume":"9","author":"Vanes","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2012.06.003","article-title":"Myelination Deficit in a Phencyclidine-Induced Neurodevelopmental Model of Schizophrenia","volume":"1469","author":"Zhang","year":"2012","journal-title":"Brain Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.schres.2014.09.040","article-title":"Myelin, Myelin-Related Disorders, and Psychosis","volume":"161","author":"Mighdoll","year":"2015","journal-title":"Schizophr. Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbi.2019.11.017","article-title":"Oligodendrocytes Modulate the Immune-Inflammatory Response in EAE via TNFR2 Signaling","volume":"84","author":"Madsen","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.4103\/1673-5374.342678","article-title":"Not Only Myelination: The Immune-Inflammatory Functions of Oligodendrocytes","volume":"17","author":"Boccazzi","year":"2022","journal-title":"Neural. Regen. Res."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Domingues, H.S., Portugal, C.C., Socodato, R., and Relvas, J.B. (2016). Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair. Front. Cell Dev. Biol., 4.","DOI":"10.3389\/fcell.2016.00071"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Sun, M., You, H., Hu, X., Luo, Y., Zhang, Z., Song, Y., An, J., and Lu, H. (2023). Microglia-Astrocyte Interaction in Neural Development and Neural Pathogenesis. Cells, 12.","DOI":"10.3390\/cells12151942"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"601939","DOI":"10.3389\/fnbeh.2020.601939","article-title":"The Hypothalamic-Pituitary-Adrenal Axis: Development, Programming Actions of Hormones, and Maternal-Fetal Interactions","volume":"14","author":"Sheng","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fpsyt.2017.00055","article-title":"The Role of Trauma and Stressful Life Events among Individuals at Clinical High Risk for Psychosis: A Review","volume":"8","author":"Mayo","year":"2017","journal-title":"Front. Psychiatry"},{"key":"ref_91","first-page":"18093","article-title":"Acute Psychosis Following Corticosteroid Administration","volume":"13","author":"Kazi","year":"2021","journal-title":"Cureus"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mikulska, J., Juszczyk, G., Gawronska-Grzywacz, M., and Herbet, M. (2021). HPA Axis in the Pathomechanism of Depression and Schizophrenia: New Therapeutic Strategies Based on Its Participation. Brain Sci., 11.","DOI":"10.3390\/brainsci11101298"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"607590","DOI":"10.3389\/fpsyt.2020.607590","article-title":"Editorial: Psychoneuroendocrinology of Psychosis Disorders","volume":"11","author":"Rutigliano","year":"2020","journal-title":"Front. Psychiatry."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1113\/jphysiol.2004.063388","article-title":"Postnatal Microbial Colonization Programs the Hypothalamic-Pituitary-Adrenal System for Stress Response in Mice","volume":"558","author":"Sudo","year":"2004","journal-title":"J. Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","article-title":"The Central Nervous System and the Gut Microbiome","volume":"167","author":"Sharon","year":"2016","journal-title":"Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2020.02.010","article-title":"The Role of the Gut Microbiome in the Development of Schizophrenia","volume":"234","author":"Kelly","year":"2021","journal-title":"Schizophr. Res."},{"key":"ref_97","unstructured":"Hyland, N., and Stanton, C. (2024). The Influence of Gut Microbiota in Psychosis. The Gut-Brain Axis, Elsevier. [2nd ed.]."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut-Brain Axis: How the Microbiome Influences Anxiety and Depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2174\/1570159X21666230222092029","article-title":"The Gut-Brain Axis and the Microbiome in Anxiety Disorders, Post-Traumatic Stress Disorder and Obsessive-Compulsive Disorder","volume":"22","author":"MacKay","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3389\/fpsyt.2020.00799","article-title":"The Gut Microbiome in Psychosis From Mice to Men: A Systematic Review of Preclinical and Clinical Studies","volume":"11","author":"Kraeuter","year":"2020","journal-title":"Front. Psychiatry"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1038\/s41380-019-0475-4","article-title":"Transplantation of Microbiota from Drug-Free Patients with Schizophrenia Causes Schizophrenia-like Abnormal Behaviors and Dysregulated Kynurenine Metabolism in Mice","volume":"25","author":"Zhu","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1126\/sciadv.aau8317","article-title":"The Gut Microbiome from Patients with Schizophrenia Modulates the Glutamate-Glutamine-GABA Cycle and Schizophrenia-Relevant Behaviors in Mice","volume":"5","author":"Zheng","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41380-022-01456-3","article-title":"A Systematic Review of Gut Microbiota Composition in Observational Studies of Major Depressive Disorder, Bipolar Disorder and Schizophrenia","volume":"27","author":"McGuinness","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/bs12040089","article-title":"The Association of the Gut Microbiota with Clinical Features in Schizophrenia","volume":"12","author":"Nocera","year":"2022","journal-title":"Behav. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Nuncio-Mora, L., Lanzagorta, N., Nicolini, H., Sarmiento, E., Ortiz, G., Sosa, F., and Genis-Mendoza, A.D. (2023). The Role of the Microbiome in First Episode of Psychosis. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061770"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host Microbiota Constantly Control Maturation and Function of Microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Misiak, B., \u0141oniewski, I., Marlicz, W., Frydecka, D., Szulc, A., Rudzki, L., and Samochowiec, J. (2020). The HPA Axis Dysregulation in Severe Mental Illness: Can We Shift the Blame to Gut Microbiota?. Prog. Neuropsychopharmacol. Biol. Psychiatry, 102.","DOI":"10.1016\/j.pnpbp.2020.109951"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bbrc.2019.02.152","article-title":"The Gut Microbiota Promotes the Pathogenesis of Schizophrenia via Multiple Pathways","volume":"512","author":"Yuan","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.2174\/1570159X19666210215123239","article-title":"Gut Microbiota Regulate Astrocytic Functions in the Brain: Possible Therapeutic Consequences","volume":"19","author":"Zhao","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1038\/tp.2016.42","article-title":"Regulation of Prefrontal Cortex Myelination by the Microbiota","volume":"6","author":"Hoban","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.biopsych.2008.06.026","article-title":"Early Life Stress Alters Behavior, Immunity, and Microbiota in Rats: Implications for Irritable Bowel Syndrome and Psychiatric Illnesses","volume":"65","author":"Marchesi","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/(SICI)1098-2302(199909)35:2<146::AID-DEV7>3.0.CO;2-G","article-title":"Maternal Separation Disrupts the Integrity of the Intestinal Microflora in Infant Rhesus Monkeys","volume":"35","author":"Bailey","year":"1999","journal-title":"Dev. Psychobiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5056\/jnm16167","article-title":"Bifidobacterium Longum and Lactobacillus Helveticus Synergistically Suppress Stress-Related Visceral Hypersensitivity Through Hypothalamic-Pituitary-Adrenal Axis Modulation","volume":"24","author":"Payard","year":"2018","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Nagy-Gr\u00f3cz, G., Spekker, E., and V\u00e9csei, L. (2024). Kynurenines, Neuronal Excitotoxicity, and Mitochondrial Oxidative Stress: Role of the Intestinal Flora. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031698"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrn.2018.1","article-title":"Imaging Structural and Functional Brain Development in Early Childhood","volume":"19","author":"Gilmore","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1038\/npp.2016.66","article-title":"Tryptophan Metabolism and White Matter Integrity in Schizophrenia","volume":"41","author":"Chiappelli","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Tsamakis, K., Galinaki, S., Alevyzakis, E., Hortis, I., Tsiptsios, D., Kollintza, E., Kympouropoulos, S., Triantafyllou, K., Smyrnis, N., and Rizos, E. (2022). Gut Microbiome: A Brief Review on Its Role in Schizophrenia and First Episode of Psychosis. Microorganisms, 10.","DOI":"10.3390\/microorganisms10061121"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Caldara, M., and Marmiroli, N. (2021). Antimicrobial Properties of Antidepressants and Antipsychotics\u2014Possibilities and Implications. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090915"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/17425255.2023.2200161","article-title":"What Is the Significance of the Impact of Antipsychotics on the Gut Microbiome?","volume":"19","author":"Seeman","year":"2023","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Bretler, T., Weisberg, H., Koren, O., and Neuman, H. (2019). The Effects of Antipsychotic Medications on Microbiome and Weight Gain in Children and Adolescents. BMC Med., 17.","DOI":"10.1186\/s12916-019-1346-1"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14740338.2022.2042251","article-title":"Does the Gut Microbiome Mediate Antipsychotic-Induced Metabolic Side Effects in Schizophrenia?","volume":"21","author":"Vasileva","year":"2022","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"112886","DOI":"10.1016\/j.bbr.2020.112886","article-title":"The Gut Microbiome and Antipsychotic Treatment Response","volume":"396","author":"Seeman","year":"2021","journal-title":"Behav. Brain Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"703452","DOI":"10.3389\/fpsyt.2021.703452","article-title":"Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders","volume":"12","author":"Murray","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.freeradbiomed.2007.01.027","article-title":"Neurodevelopmental Damage after Prenatal Infection: Role of Oxidative Stress in the Fetal Brain","volume":"42","author":"Meunier","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/schbul\/sby125","article-title":"Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-Analysis","volume":"45","author":"Fraguas","year":"2019","journal-title":"Schizophr. Bull."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"J\u00eetc\u0103, G., \u0150sz, B.E., Tero-Vescan, A., and Vari, C.E. (2021). Psychoactive Drugs\u2014From Chemical Structure to Oxidative Stress Related to Dopaminergic Neurotransmission. A Review. Antioxidants, 10.","DOI":"10.3390\/antiox10030381"},{"key":"ref_127","first-page":"141","article-title":"Dopaminergic Neuron-Specific Oxidative Stress Caused by Dopamine Itself","volume":"62","author":"Miyazaki","year":"2008","journal-title":"Acta Med. Okayama"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Rambaud, V., Marzo, A., and Chaumette, B. (2022). Oxidative Stress and Emergence of Psychosis. Antioxidants, 11.","DOI":"10.3390\/antiox11101870"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0920-9964(02)00405-X","article-title":"Dopamine-Induced Oxidative Stress in Neurons with Glutathione Deficit: Implication for Schizophrenia","volume":"62","author":"Grima","year":"2003","journal-title":"Schizophr. Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/s41380-021-01374-w","article-title":"Caught in Vicious Circles: A Perspective on Dynamic Feed-Forward Loops Driving Oxidative Stress in Schizophrenia","volume":"27","author":"Cuenod","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Vall\u00e9e, A. (2022). Neuroinflammation in Schizophrenia: The Key Role of the WNT\/\u03b2-Catenin Pathway. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052810"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrn.2015.19","article-title":"Linking Early-Life NMDAR Hypofunction and Oxidative Stress in Schizophrenia Pathogenesis","volume":"17","author":"Hardingham","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2014.06.021","article-title":"Redox Dysregulation, Neuroinflammation, and NMDA Receptor Hypofunction: A \u201cCentral Hub\u201d in Schizophrenia Pathophysiology?","volume":"176","author":"Steullet","year":"2016","journal-title":"Schizophr. Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.biopsych.2005.02.024","article-title":"Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia","volume":"57","author":"Rapaport","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"ref_135","first-page":"CD008919","article-title":"Antioxidant Treatments for Schizophrenia","volume":"2016","author":"Dean","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0166-2236(89)90165-3","article-title":"Cytochrome Oxidase: An Endogenous Metabolic Marker for Neuronal Activity","volume":"12","year":"1989","journal-title":"Trends Neurosci."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-1119(01)00385-7","article-title":"Mammalian Subunit IV Isoforms of Cytochrome c Oxidase","volume":"267","author":"Kadenbach","year":"2001","journal-title":"Gene"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mito.2020.11.009","article-title":"Mitochondrial Dysfunction in Schizophrenia: With a Focus on Postmortem Studies","volume":"56","author":"Roberts","year":"2021","journal-title":"Mitochondrion"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000441252","article-title":"Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia","volume":"1","author":"Hjelm","year":"2015","journal-title":"Complex Psychiatry"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neubiorev.2014.11.005","article-title":"Mitochondrial Dysfunction in Schizophrenia: Pathways, Mechanisms and Implications","volume":"48","author":"Rajasekaran","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial Dysfunction in Schizophrenia: Evidence for Compromised Brain Metabolism and Oxidative Stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1172\/JCI100639","article-title":"The Lactic Acid and Glutathione Content of the Blood of Schizophrenic Patients 1","volume":"13","author":"Looney","year":"1934","journal-title":"J. Clin. Investig."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.mp.4001711","article-title":"Mitochondrial Dysfunction in Bipolar Disorder: Evidence from Magnetic Resonance Spectroscopy Research","volume":"10","author":"Stork","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.biopsych.2008.11.010","article-title":"Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis","volume":"65","author":"Regenold","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1046\/j.1471-4159.1994.63031126.x","article-title":"Identification of Catechol-Protein Conjugates in Neostriatal Slices Incubated with [3H]Dopamine: Impact of Ascorbic Acid and Glutathione","volume":"63","author":"Hastings","year":"1994","journal-title":"J. Neurochem."},{"key":"ref_146","first-page":"1309","article-title":"Dopamine Induces Apoptotic Cell Death of a Catecholaminergic Cell Line Derived from the Central Nervous System","volume":"50","author":"Masserano","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.bcp.2004.02.015","article-title":"Dopamine Toxicity Involves Mitochondrial Complex I Inhibition: Implications to Dopamine-Related Neuropsychiatric Disorders","volume":"67","author":"Zuk","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/S0024-3205(00)80002-8","article-title":"The Specificity of Platelet Glutamate Receptor Supersensitivity in Psychotic Disorders","volume":"66","author":"Berk","year":"2000","journal-title":"Life Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative Stress in Schizophrenia: An Integrated Approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/schbul\/sbu048","article-title":"Oxidative\/Nitrosative Stress in Psychiatric Disorders: Are We There Yet?","volume":"40","author":"Do","year":"2014","journal-title":"Schizophr. Bull."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1104\/pp.106.077073","article-title":"Reactive Species and Antioxidants. Redox Biology Is a Fundamental Theme of Aerobic Life","volume":"141","author":"Halliwell","year":"2006","journal-title":"Plant Physiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0022-510X(90)90025-I","article-title":"Delayed Decreases in Specific Brain Mitochondrial Electron Transfer Complex Activities and Cytochrome Concentrations Following Anoxia\/Ischemia","volume":"100","author":"Wagner","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0019-5545.43627","article-title":"A Comparative Study of Oxidative Stress and Interrelationship of Important Antioxidants in Haloperidol and Olanzapine Treated Patients Suffering from Schizophrenia","volume":"50","author":"Singh","year":"2008","journal-title":"Indian. J. Psychiatry"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","article-title":"Decreased Glutathione Levels and Antioxidant Enzyme Activities in Untreated and Treated Schizophrenic Patients","volume":"33","author":"Raffa","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1089\/ars.2010.3508","article-title":"Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia","volume":"15","author":"Chowdari","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jpsychires.2013.06.018","article-title":"Mitochondrial Activity and Oxidative Stress Markers in Peripheral Blood Mononuclear Cells of Patients with Bipolar Disorder, Schizophrenia, and Healthy Subjects","volume":"47","author":"Gubert","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20110367","article-title":"Mitochondrial Reactive Oxygen Species Drive Proinflammatory Cytokine Production","volume":"208","author":"Naik","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0960327113493305","article-title":"Inflammation and Schizophrenia: Alterations in Cytokine Levels and Perturbation in Antioxidative Defense Systems","volume":"33","author":"Khan","year":"2014","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0269881114553647","article-title":"Recent Genetic Findings in Schizophrenia and Their Therapeutic Relevance","volume":"29","author":"Harrison","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.schres.2019.03.010","article-title":"NMDA Receptor Hypofunction for Schizophrenia Revisited: Perspectives from Epigenetic","volume":"217","author":"Snyder","year":"2020","journal-title":"Mechanisms. Schizophr. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/sj.mp.4001558","article-title":"Schizophrenia Genes, Gene Expression, and Neuropathology: On the Matter of Their Convergence","volume":"10","author":"Harrison","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/ajmg.b.32567","article-title":"Microbiome, Inflammation, Epigenetic Alterations, and Mental Diseases","volume":"174","author":"Alam","year":"2017","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genetics"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in Reelin and Glutamic Acid Decarboxylase67 (GAD67) Expression in Schizophrenia and Bipolar Disorder","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Negr\u00f3n-Oyarzo, I., Lara-V\u00e1squez, A., Palacios-Garc\u00eda, I., Fuentealba, P., and Aboitiz, F. (2016). Schizophrenia and Reelin: A Model Based on Prenatal Stress to Study Epigenetics, Brain Development and Behavior. Biol. Res., 49.","DOI":"10.1186\/s40659-016-0076-5"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"823708","DOI":"10.3389\/fncel.2022.823708","article-title":"Histone Acetylation and Methylation Underlie Oligodendroglial and Myelin Susceptibility in Schizophrenia","volume":"16","author":"Li","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/s41380-019-0601-3","article-title":"Epigenetic Mechanisms in Schizophrenia and Other Psychotic Disorders: A Systematic Review of Empirical Human Findings","volume":"25","author":"Smigielski","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Wawrzczak-Bargie\u0142a, A., Bilecki, W., and Ma\u0107kowiak, M. (2023). Epigenetic Targets in Schizophrenia Development and Therapy. Brain Sci., 13.","DOI":"10.3390\/brainsci13030426"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.euroneuro.2016.01.009","article-title":"Biomarkers for Drug Development in Early Psychosis: Current Issues and Promising Directions","volume":"26","author":"Goff","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.3389\/fimmu.2019.02971","article-title":"Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations","volume":"10","author":"Fransen","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s40495-021-00260-x","article-title":"Possible Biomarkers and Contributing Factors of Psychosis: A Review","volume":"7","author":"Yadav","year":"2021","journal-title":"Curr. Pharmacol. Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41386-024-01814-5","article-title":"Matrix Metalloproteinase 9 (MMP-9) Activity, Hippocampal Extracellular Free Water, and Cognitive Deficits Are Associated with Each Other in Early Phase Psychosis","volume":"49","author":"Cho","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1515\/mr-2022-0009","article-title":"Potential Diagnostic Biomarkers for Schizophrenia","volume":"2","author":"Yue","year":"2022","journal-title":"Med. Rev."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1180720","DOI":"10.3389\/fpsyt.2023.1180720","article-title":"Decreased Plasma Neuropeptides in First-Episode Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Associations with Clinical Symptoms and Cognitive Function","volume":"14","author":"Yu","year":"2023","journal-title":"Front. Psychiatry"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2020.02.012","article-title":"The Gut-Microbiome as a Target for the Treatment of Schizophrenia: A Systematic Review and Meta-Analysis of Randomised Controlled Trials of Add-on Strategies","volume":"234","author":"Minichino","year":"2021","journal-title":"Schizophr. Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/HRP.0000000000000109","article-title":"Progress and Future Directions in Research on the Psychosis Prodrome","volume":"24","author":"Woodberry","year":"2016","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-019-0090-z","article-title":"The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and a Roadmap for Future Research","volume":"6","author":"Potkin","year":"2020","journal-title":"NPJ Schizophr."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Chen, E.Y.H., and Wong, S.M.Y. (2024). Unique Challenges in Biomarkers for Psychotic Disorders. Brain Sci., 14.","DOI":"10.3390\/brainsci14010106"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Pimental, M., Mathur, R., and Barlow, G.M. (2023). Gut Microbes: The Gut Brain Connection. Clinical Understanding of the Human Gut Microbiome, Springer Nature.","DOI":"10.1007\/978-3-031-46712-7"}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/13\/6\/709\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:57:09Z","timestamp":1760108229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/13\/6\/709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":178,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["antiox13060709"],"URL":"https:\/\/doi.org\/10.3390\/antiox13060709","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]}}}